Skip to Content
Contact Form Map & Directions Videos

U.S. Supreme Court Reviews Generic Drugs

01/9/2013
Articles
BY

Next spring, the U.S. Supreme Court will soon look at the very profitable policy called “pay for delay.” Profitability in this case extends primarily to both the brand-name manufacturers and generic drug makers at the expense of the consumer. Estimates are “pay for delay,” costs consumers an extra $3.5.8 billion […]

Read More

Vioxx Saga Not Yet Over

01/9/2013
Defective Drugs
BY

How much can one bad drug cost a company? Just ask Merck. When its painkiller drug Vioxx was pulled from the market in 2004, Merck was facing 27,000 lawsuits which culminated in a $4.85.8 billion settlement. Then last year the U.S Department of Justice reached a $950 million civil and […]

Read More

Hear What Our Clients Have To Say

"Every question that I had was answered in mere minutes and the follow through that the staff, secretaries and attorneys had was superior. I have dealt with many, many firms that have all disappointed me and Searcy Denney was by far the most thorough - I highly recommend them!"
Posted By: Susan Baker